To observe the effect of Yinzhihuang Granules（茵栀黄颗粒）combined with ursodeoxycholic acid on the efficacy and liver function of patients with chronic jaundice hepatitis B.

A totalof132 patientswith chronic jaundice hepatitis B were enrolled in the hospital and random ly divided into observation group and control group according to the random number table method，with 66 cases in each group.The control group was treated with ursodeoxycholic acid，and the observation group was treated with Yinzhihuang Granules combined with ursodeoxycholic acid.The clinical efficacy，liver function，traditional Chinese medicine syndrome score，hepatitis B virus deoxyribonucleic acid（HBV DNA）negative conversion rate and occurrence of adverse reactions were observed in the two groups before and after treatment.

After treatment，the total effective rate of the observation group was 89.39%，which was significantly higher than that of the control group（74.24%）（P<0.05）.The liver functions of the two groups were alanine aminotransferase（ALT），aspartate aminotransferase（AST），total bilirubin（TBIL），total bile acids（TBA）andγ-glutamyl transferase（GGT）were all lower than those before treatment（P<0.05），while observing the liver function indicators of the observation group were significantly lower than those of the control group（P<0.05）.The TCM syndrome scores of the two groups were significantly lower than those before treatment（P<0.05）.At the same time，the TCM syndrome scores of the observation group were significantly lower than those of the controlgroup（P<0.05）.The HBV DNA negative conversion rate in the observation group was 56.06%，and that in the control group was 28.79%.The negative conversion rate in the observation group was significantly higher than that in the control group（P<0.05）.The incidence of liver injury in the observation group was 1.52%，which was significantly lower than that（13.64%）in the control group（P<0.05）.The incidence of adverse reactions in the observation group was 3.03%，which was not significant compared with that（10.61%）in the control group（P>0.05）.

Yinzhihuang Granules combined with ursodeoxycholic acid has a significant effect on patientswith chronic jaundice hepatitis B.It can effectively improve the clinical symptoms and liver function of patients，promote the HBV DNA negative conversion rate，and reduce the incidence of adverse reactions.

The differential metabolites of Sangshen（Mori Fructus）with different maturities were studied to provide reference for the determination of Sangshen（Mori Fructus）harvest time.

Based on the metabolo micsmethod，the changes of chemical components in Sangshen（Mori Fructus）with different maturities were explored.The data of secondary metabolites in mulberry fruits was collected by ultra-high performance liquid chromatography-quadrupole/exactive Orbitrap mass spectrometry（UPLC-Q-Exactive Orbitrap MS）.Multivariate statistical analysis methods such as principal component analysis（PCA）and partial least squares discriminant analysis（PLS-DA）were used to explore the differences in metabolic components of Sangshen（Mori Fructus）with different maturities.

There were significant differences in the metabolites of Sangshen（Mori Fructus）with different maturities.A total of176 compounds in 11 categories were screened.Flavonoids and organic acids accounted for 23.30% and 21.02%，respectively.The contents of most screened flavonoids and organic acid differential metabolites increased with the increase of maturity，and the flavonoids and organic acid metabolites of Sangshen（Mori Fructus）of different germplasms were different.The contents of extract，total flavonoids，total polyphenols and rutin in the mature stage were higher than those in the immature stage.The antioxidant activity in the mature stage was stronger than that in the immature stage.The content of chlorogenic acid in the immature stage was higher than that in the mature stage，and the inhibitory effectonα-glucosidase was also stronger than that in the mature stage.

There are obvious differences in the metabolites of Sangshen（Mori Fructus）with different maturities.The contents of chemical components in Sangshen（Mori Fructus）are related to different maturities.Based on the antioxidant effect，it is better to harvest when Sangshen（Mori Fructus）is dark purple（mature）.Based on the hypoglycemic effect，it is better to harvest when the Sangshen（Mori Fructus）becomes red（immature），which provides a basis for the quality control of Sangshen（Mori Fructus）and the determination of harvesting time.

To study the effects of Yifei JianpiRecipe（益肺健脾方）on aquaporin 3（AQP3），aquaporin 5（AQP5）and mucin 5AC（MUC5AC）in bronchial and lung tissues of chronic obstructive pulmonary disease（COPD）model ratswith lung and spleen deficiency syndrome.

Sprague-dawley rats were randomly segmented into blank group，model group，ambroxol group，dexamethasone group and Yifei Jianpi Recipe high，medium and low dose groups.The COPD ratmodel of lung and spleen deficiency was created by fumigation combined with lipopolysaccharide tracheal drip and Senna gavage and the pathologic morphology of bronchopulmonary tissues in rats was observed by hematoxylin-eosin（HE）staining and Alcian Blue-Periodic Acid Schiff（AB-PAS）staining，and the m RNA expressions of AQP3，AQP5 and MUC5AC in ratbronchopulmonary tissueswere detected by RT-qPCR，and protein expressions of AQP3，AQP5 and MUC5ACwere detected by Western Blot and immunohisto chemistry（IHC）methods，the mRNA expressions of AQP3，AQP5 and MUC5AC in rat bronchopulmonary tissues were detected by quantitative real-time polymerase chain reaction（RT-qPCR），and the protein expressions of AQP3，AQP5 and MUC5AC in rat bronchopulmonary tissues were detected by Western Blotand IHC methods.

Compared with those in the sham group，the bronchopulmonary tissues of rats in themodel group showed different degrees of damage，and HE staining demonstrated that there were tangible inflammatory cell infiltration in the airways of rats，and AB-PASstaining reviewed thata good deal of cupshaped cell hyperplasia could be seen in the bronchial tubes of rats.ThemRNA and protein expressions of AQP3 and AQP5 were significantly decreased and MUC5AC mRNA and protein expressions were clearly increased in the model group（P<0.01）.Compared with those in the modelgroup，the inflammatory pathology damage of the bronchopulmonary tissues and the proliferation of cup cells in the rats of each dose group showed different degrees of improvement，and the m RNA and protein expressions of AQP3 and AQP5 were increased to different degrees.Among them，the Yifei Jianpi Recipe high dose group，the aminoglossum group and the dexamethasone group showed significant and comparable levels of increase（P<0.05）；the MUC5AC mRNA and protein expressions were reduced to different degrees，among which the ambroxol group，the dexamethasone group and the Yifei Jianpi Recipe high dose group showed significant and comparable reductions（P<0.01）.

Yifei Jianpi Recipe can inhibit airway mucus hypersecretion and reduce airway inflammation in COPD model rats with lung and spleen deficiency syndrome，and its mechanism is related to up-regulation of AQP3 and AQP5 and down-regulation of MUC5AC transcription and expression.

To investigate the correlation between different types of refractory peptic ulcer（RPU）and clinical manifestations，and to provide clinical basis for the prevention and treatment of this disease in modern medicine.

A crosssectional study was conducted to retrospectively collect the general data，clinical medical records，tongue and pulse conditions，TCM syndromes and other related factors of130 patients with RPU who were hospitalized in the Department of Gastroenterology of Zhengzhou People's Hospital from January 1，2020 to September30，2023.The collected data was statistically analyzed to explore the relationship between different types of RPU and clinical manifestations.

（1）There was no significant difference between the types of RPU and the distribution of tongue and pulse.（2）In terms of disease location syndrome elements，the mostusual disease location syndrome elements of RPU were heart and stomach（100.00%），the others were spleen（43.08%）and liver（30.00%）；in terms of disease nature syndrome elements，the most usual disease nature syndrome elements were spleen and stomach weakness（cold）syndrome（28.46%），followed by liver-stomach disharmony syndrome（21.54%），blood stasis in stomach collateral syndrome（16.15%），damp-heat in spleen and stomach syndrome（14.62%），stomach Yin deficiency syndrome（10.77%），liver-stomach heat stagnation syndrome（8.46%）.（3）There was no significant difference in hypertension，coronary heart disease and weight among the three groups（P>0.05）.There were significant differences in gender，Helicobacter pylori（Hp）infection，smoking history，diabetes，age，height and oral non-steroidal anti-inflammatory drugs（NSAIDs）（P<0.05）.Oralad ministration of NSAIDs is a risk factor for refractory compound ulcer and refractory duodenalulcer.Coronary heart disease，height and Hp infection are risk factors for refractory gastric ulcer.

The patients with Hp infection have a higher probability of refractory gastric ulcer.The patients with smoking history，diabetes and NSAIDs are more likely to develop refractory duodenal ulcer.Patients with different ages and heights are prone to RPU types.Oral administration of NSAIDs is a risk factor for refractory compound ulcer and refractory duodenal ulcer.Coronary heart disease，height and Hp infection are risk factors for RPU.

To explore the clinical efficacy of Jianpi Lishi Jiedu Decoction（健脾利湿解毒汤）combined with pidotimod in the treatment of low-grade squamous intraepithelial lesions（LSIL）of the cervix combined with high-risk human papillomavirus（HPV）infection.

A totalof130 cases of LSIL complicated with high-risk HPV infection admitted to the hospital from January 2022 to September 2023 were included and divided into two groups using the computer random number table method，with 65 cases in each group.The control group was treated with pidotimod，while the observation group was treated with Jianpi Lishi Jiedu Decoction on the basis of the control group.The treatment lasted for 3 months.The clinical efficacy of two groups，the traditional Chinese medicine syndrome score and serum inflammatory factor levels［high-sensitivity C-reactive protein（hs-CRP），interleukin-12（IL-12）and tumor necrosis factorα（TNF）-α）］and changes in viral load were compared.

①The total effective rate of the observation group was 93.85%，which was higher than that（81.54%）of the control group（χ²＝4.561，P＝0.033）.②The difference in traditional Chinese medicine syndrome scores for vaginal discharge，itching，fatigue，edema and loose stools in the observation group was lower than that in the control group［（1.13±0.13）points vs.（2.05±0.16）points，（1.09±0.11）points vs.（1.65±0.15）points，（1.01±0.19）points vs.（1.66±0.22）points，（0.68±0.17）points vs.（1.13±0.19）points，（0.89±0.18）points vs.（1.38±0.14）points］（t＝35.979～17.324，all P<0.01）.③The serum levels of TNF-α and hs-CRP of the observation group were all lower than those of the control group［（1.13±0.36）pg/mL vs.（1.72±0.41）pg/mL，（2.19±0.45）mg/L vs.（4.24±0.87）mg/L］（t＝8.718-16.874，all P<0.01），and the serum IL-12 levels were higher than the control group［（16.52±5.03）pg/mL vs.（14.25±5.16）pg/mL］（t＝-2.540，P＝0.006）.④The recurrence rate［4.61%（3/65）］in the observation group was significantly lower than that［16.92%（11/65）］in the control group（χ²＝5.123，P＝0.024）.The HPV viral load in the observation group was lower than that in the control group［（1.85±0.59）Igcopies/mL vs.（2.73±0.65）Igcopies/mL］（t＝-8.082，P<0.01），and the seroconversion rate was higher than that in the control group（69.23% vs.43.08%）（χ² ＝9.029，P＝0.003）.

The combination of Jianpi Lishi Jiedu Decoction and pidotimod in the treatment of LSIL complicated with high-risk HPV infection has a definite therapeutic effect.It can restore the patient's immune inflammatory balance and reduce the HPV viral load.

To investigate the efficacy and safety of Sanhuangtangshenkang（三黄糖肾康）combined with Dapagliflozin in the treatment of Qi deficiency and blood stasis type of early diabetic nephropathy（DN）.

A randomized，double-blind and placebo-controlled clinical trial was conducted involving 120 patients from the Endocrinology and Nephrology Departments at Taizhou Hospital of Traditional Chinese Medicine from June 2021 to June 2023.The participants were allocated into two groups.The experimental group（60 patients）received standard care augmented with Sanhuangtangshenkang and Dapagliflozin，while the control group（60 patients）was treated with standard care plus placebo granules and Dapagliflozin.The duration of treatmentwas 12 weeks.The primary endpoints included the efficacy of treatment，the renal function，the inflammatory markers，the enhancement of traditional Chinese medicine（TCM）syndromes，and the frequency of adverse events.

A total of 117 patients were successfully enrolled，59 in the experimental group and 58 in the control group.The experimental group showed a significantly higher overall effective rate compared to the control group（98.30% versus70.68%，P<0.05）.Biochemical indicators such as the urine albumin-to-creatinine ratio（UACR），24-hour urinary microalbumin（UMA）and 24-hour urinary protein were significantly improved in the experimental group compared to those in the control group after 12 weeks of treatment（P<0.05）.Inflammatory markers including serum amyloid A（SAA），interleukin-6（IL-6），C-reactive protein（CRP）and homocysteine（Hcy）also showed more significant reductions in the experimental group，especially after 12 weeks of treatment（P<0.05）.The improvements in renal function and other biochemical indicators，such as glycated hemoglobin（HbA1c），estimated glomerular filtration rate（eGFR）and total cholesterol（TC），were also notably better in the experimental group（P<0.05）.TCM symptom scores further confirmed the improvement in various indicators in the experimental group after treatment（P<0.05）.Although there was no statistically significant difference in the incidence of adverse reactions between the two groups（P>0.05）.The experimental group exhibited a lower rate of adverse reactions（3.38%）compared to the control group（8.62%）.

The combination of Sanhuangtangshenkang with Dapagliflozin is highly effective and safe for improving renal function，glycemic control and TCM syndromes in patients with early-stage DN characterized by Qi deficiency and blood stasis，demonstrating both enhanced safety and superior efficacy.

To establish amethod for identifying Shicangpu（Acori Tatarinowii Rhizoma）（ATR）from common counterfeits by ultra performance liquid chromatography（UPLC）technology，and to provide reference for quality evaluation and control of ATR.

Waters CORTECST3 column（2.1 mm×150 mm，1.6μm）was used.Methanol：acetonitrile 1：1（A）-water（B）solution was used as mobile phase and gradientelution was performed.The flow ratewas0.2mL/min.The column temperature was40℃.The detection wavelength was275 nm and the sample volume was3μL.The UPLC characteristic map was established to identify ATR from common counterfeits.

The UPLC characteristic map identified 4 common peaks of ATR and identified 1 of them.The similarity among samples was 0.892～0.996.

The established method of characteristic map is simple，reliable，accurate and repeatable，which can identify the authenticity of ATR directly，provide a specific method for the quality control and authenticity identification of ATR，and effectively improve the drug safety of related products.